Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 18Brain Neoplasms 18Glioblastoma 16Glioma 15Carcinoma, Basal Cell 7Astrocytoma 5Gliosarcoma 4Skin Neoplasms 3Precancerous Conditions 3Oligodendroglioma 3Mouth Neoplasms 3Carcinoma, Squamous Cell 3Squamous Intraepithelial Lesions 2Skull Base Neoplasms 2Sarcoma 2Pituitary Neoplasms 2Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Oropharyngeal Neoplasms 1Nonmelanoma Skin Cancers 1Non-Melanoma Skin Cancer (NMSC) 1Neurofibromatosis 1 1Neurofibromatoses 1

Interventions

sonidegib 2methyl 5-aminolevulinate 1folfirinox 1Taxes 1Risk Factors 1Oxaliplatin 1Lighting 1Leucovorin 1Irinotecan 1Infectious Disease Incubation Period 1HhAntag691 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1BF-200 ALA 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Basal Cell × Aminolevulinic Acid × Clear all
NCT02367547 2019-03-28

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Unknown
117 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡